Caring Brands (CABR) Non-Current Assets (2024 - 2025)
Caring Brands' (CABR) quarterly Non-Current Assets came in at $3.1 million in Q3 2025, down 6.72% quarter-over-quarter from $3.4 million in Q4 2024.
Caring Brands (CABR) Non-Current Assets (2024 - 2025) Analysis & Trends
Caring Brands' Non-Current Assets history runs 2 years deep, the most recent figure standing at $3.1 million for Q3 2025.
- On a quarterly basis, Non-Current Assets changed N/A year-over-year to $3.1 million in Q3 2025; TTM through Dec 2024 was $3.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.4 million, changed N/A from the prior year.
- Non-Current Assets declined to $3.1 million in Q3 2025 per CABR's latest filing, from $3.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.4 million in Q4 2024 and bottomed at $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.35 Mn |